DMD: pharmacology trials-1

  • WAVE: A Multicenter, Double-blind, Placebo-controlled, Phase 1 Study of WVE-210201 Administrated Intravenously to Patients with Duchenne Muscular Dystrophy
  • WAVE-OLE: A Multicenter, Open-Label Extension Study of WVE-210201 in Patients previously enrolled in WVE-DMDX51-001

Acronym

WAVE

WAVE-OLE

Study type BMR BMR
Trial type Multicentre trial Multicentre trial
Intervention WVE-210201 WVE-210201
Principal investigator Teresa Gidaro Teresa Gidaro
Sponsor WAVE WAVE
Study status Ongoing Ongoing
Recruitment status Ongoing Ongoing
Population Child Child
Contact t.gidaro@institut-myologie.org t.gidaro@institut-myologie.org
+ infos sur clinicaltrials.gov